AGT and cardiac hypertrophy: Constitutive NO has been identified as an important modulator of cardiac hypertrophy as chronic inhibition of NO synthase, using L-nitroarginine methyl ester (L-NAME), has been shown to significantly increase angiotensin II-induced cardiac fibrosis in rats [106].